Issue 6, 2015

Discovery of a series of 2-(pyridinyl)pyrimidines as potent antagonists of GPR40

Abstract

A series of 2-(pyridinyl)pyrimidines were identified as potent GPR40 antagonists. Despite significant challenges related to improving the combination of potency and lipophilicity within the series, the compounds were optimised to identify a suitable in vivo probe compound, which was confirmed to exhibit pharmacology consistent with GPR40 antagonism.

Graphical abstract: Discovery of a series of 2-(pyridinyl)pyrimidines as potent antagonists of GPR40

Supplementary files

Article information

Article type
Concise Article
Submitted
28 Jan 2015
Accepted
01 Apr 2015
First published
08 Apr 2015

Med. Chem. Commun., 2015,6, 1024-1029

Author version available

Discovery of a series of 2-(pyridinyl)pyrimidines as potent antagonists of GPR40

M. J. Waring, D. J. Baker, S. N. L. Bennett, A. G. Dossetter, M. Fenwick, R. Garcia, J. Georgsson, S. D. Groombridge, S. Loxham, P. A. MacFaul, K. G. Maskill, D. Morgan, J. Morrell, H. Pointon, G. R. Robb, D. M. Smith, S. Stokes and G. Wilkinson, Med. Chem. Commun., 2015, 6, 1024 DOI: 10.1039/C5MD00037H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements